Institution Theme Category Industry
  • State Street
  • Governance
  • Strategy & Risk
  • Healthcare
Company Year Market Link
Mylan N.V.’s 2020 N/A https://www.ssga.com/library-content/products/esg/asset-stewardship-report-q2-2020.pdf

In our engagement with global pharmaceutical company Mylan, we discussed the company’s decentralized global supply-chain system that has various production facilities across the globe. As COVID-19 hit different areas of the world at different times, Mylan was able to navigate and leverage the different aspects of its supply chain, allowing it to experience minimal disruptions and deliver critical medicines to patients.

Details

  • Proponent
  • Engagement
  • Resolution
  • COVID-19 impact on supply chain
  • Vote
  • N/A
  • Rationale
  • N/A
  • Details
  • N/A